Studying the Power of Therapy Resistance

With support from a $3.3 million federal grant Virginia Borges, MD, and Traci Lyons, PhD, will investigate how a molecule they’ve been studying for a decade is able to promote resistance to therapies for a major type of breast cancer in the hopes of determining how to switch off the molecule’s harmful interference.

Exciting Updates for Bladder Cancer Treatment

At this years annual NCCN Conference in Orlando Dr. Flaig was excited to share the effectiveness of enfortumab vedotin, a new antibody drug conjugate that targets a particular or a bladder cancer cell and then delivers chemotherapy directly to that cell.

Rise in Colon Cancer Among Younger Populations

According to Dr. Chris Lieu, colon cancer is becoming the number one cancer-related issue in younger populations, with The American Cancer Society expecting more than 150,000 people to be diagnosed with colorectal cancer in 2024.

How a Passion for Research Can Improve Patient Care

Dr. Baiyee discusses how her love of research has not only allowed her to improve patient care but also  advance medicine. "It’s not just about taking care of patients, as far as their disease, but more holistically. My goal is to make this really, really hard experience as tolerable as possible and to offer them all the support we have"

Research Seeks Enhance Cellular Immunotherapy

Dr. Davila was recently awarded the Anschutz Acceleration Initiative Grant, he sits down to discuss his aim to enhance all forms of cellular immunotherapy has been awarded the Anschutz Acceleration Initiative Grant. 

Discussing the Merits of Second Opinions with Dr. Messersmith

Dr. Messersmith discusses the ways in which a second opinion can boost patient confidence in the diagnosis and treatment recommendations.

TORI; Advancing Cancer Research Through Collaboration

The Thoracic Oncology Research Initiative (TORI), led by Dr. Sharon Pine, brings together investigators from multiple departments and centers across the CU Anschutz Medical Campus to advance lung cancer research.

Discussing the Impact of a Stage 4 Colorectal Cancer Diagnosis

Dr. Lieu discusses what a stage 4 colon cancer diagnosis means for patients and treatment methods.

Discussing the Importance of Clinical Trials in Breast Cancer

Clinical trials over the years have resulted in new drugs that prolong life and prevent cancer from spreading and Dr. Diamond discusses their importance and impact in breast cancer research. 

Dr. Camidge Honored By IASLC

Ross Camidge, MD, PhD, received the Daniel C. Ihde Lectureship Award for Medical Oncology from the International Association for the Study of Lung Cancer. The award is named for the influential lung cancer researcher and former longtime deputy director of the National Cancer Institute.

Tejas Patil, MD, Joins ALK Positive to Discuss Trials

Robert Lentz, MD, Recipient of the 2023 ACS Grant

Robert Lentz, MD, received funding to test the combination of two drugs in colorectal and pancreas ductal adenocarcinoma. “Metastatic colorectal and pancreas ductal adenocarcinoma are common and deadly and frequently harbor KRAS mutations, novel treatments are desperately needed.”